Europe Varicose Vein Treatment Market

Europe Varicose Vein Treatment Market Size 

The Europe Varicose Vein Treatment Market was valued at USD 107.8 million in 2024. The Europe Varicose Vein Treatment Market is expected to have 6.3 % CAGR from 2025 to 2033 and be worth USD 186.82 million by 2033 from USD 114.59 million in 2025.  

Factors propelling the growth of the European varicose Vein Treatment Market include increased patient compliance and reliability, increased healthcare costs, and rapid aging growth.

The varicose vein treatment market in Europe is mainly due to the emergence of durable and safe technologies to address the enormous burden of varicose veins and increased access to varicose vein medical devices, owing to patient compliance. Furthermore, there is a new trend in the healthcare industry to remove or destroy superficial veins, improving the patient experience. The European Varicose Vein Treatment Market growth in the future is further driven by an increased incidence of varicose veins, an increasing elderly population, advanced varicose vein treatment devices, occupational involvement in increasing the prevalence of varicose veins, and technological advances. Also, increasing levels of awareness and the development of emerging markets have created many opportunities in the European Varicose Vein Treatment Market.  is performed comprehensively in primary and secondary regions to understand growth factors and factors that hinder the market growth.The challenges associated with inconsistent reimbursement scenarios in treatment procedures and the sustainability of key players in this highly competitive marketplace can limit European Market growth.

REGIONAL ANALYSIS

Geographically, the European government's aggressive action and the growing popularity of advanced therapies are supposed to have a positive impact on market growth. As of 2019, the European varicose vein treatment device market is transitioning to non-invasive medical procedures and expensive surgical procedures for vena cava treatment. Europe's Varicose Vein Treatment Market is likely to be the fastest-growing market due to the developing healthcare infrastructure, rise in patient awareness, soaring disposable income, and benefits of early treatments for varicose vein cases in nations like the UK, Germany, France, Spain, Italy, Norway, and others.

KEY MARKET PLAYERS

Some of the Promising Companies leading the Europe Varicose Vein Treatment Market Profiled in the Report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.)

MARKET SEGMENTATION

This research report segmented and sub-segmented the European varicose Vein Treatment Market into the following categories.

By Treatment Types

• Surgical Treatments

  • Vein Ligation and Stripping

  • Phlebectomy

• Non-Surgical Treatments

  • Laser Therapy

  • Trans-Illuminated Powered Phlebectomy (Trivex)

• Radiofrequency Ablation

  • Sclerotherapy

By Device

• Ablation devices

  • Radiofrequency Ablation Devices

  • Laser Ablation Devices

• Venous Closure Products

• Surgical Products

By End-User

• Surgery Centres

• Hospitals

  • Specialty Hospitals

  • Multispecialty Hospitals

By Country 

• UK

• France

• Spain

• Germany

• Italy

• Russia

• Sweden

• Denmark

• Switzerland

• Netherlands

• Turkey

• Czech Republic

• Rest of Europe